DK2062569T3 - Vaginalt afgivelsessystem - Google Patents
Vaginalt afgivelsessystemInfo
- Publication number
- DK2062569T3 DK2062569T3 DK07397043.6T DK07397043T DK2062569T3 DK 2062569 T3 DK2062569 T3 DK 2062569T3 DK 07397043 T DK07397043 T DK 07397043T DK 2062569 T3 DK2062569 T3 DK 2062569T3
- Authority
- DK
- Denmark
- Prior art keywords
- delivery system
- core
- compartment
- drospirenone
- vaginal delivery
- Prior art date
Links
- 208000034423 Delivery Diseases 0.000 title 1
- 230000009677 vaginal delivery Effects 0.000 title 1
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 abstract 2
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 abstract 2
- 229960004845 drospirenone Drugs 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07397043A EP2062569B1 (en) | 2007-11-22 | 2007-11-22 | Vaginal delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2062569T3 true DK2062569T3 (da) | 2011-08-29 |
Family
ID=39273813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07397043.6T DK2062569T3 (da) | 2007-11-22 | 2007-11-22 | Vaginalt afgivelsessystem |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2062569B1 (da) |
| AT (1) | ATE508734T1 (da) |
| DK (1) | DK2062569T3 (da) |
| ES (1) | ES2365552T3 (da) |
| PL (1) | PL2062569T3 (da) |
| PT (1) | PT2062569E (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20095563A7 (fi) * | 2009-05-20 | 2010-11-21 | Bayer Schering Pharma Oy | Vaginaalinen antojärjestelmä |
| US20200276110A1 (en) * | 2015-12-21 | 2020-09-03 | Bayer Oy | A method of manufacturing a vaginal ring |
| CN110585246B (zh) * | 2019-09-22 | 2020-06-02 | 深圳市多微生保健食品有限公司 | 一种阴道抑菌制剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4469671A (en) * | 1983-02-22 | 1984-09-04 | Eli Lilly And Company | Contraceptive device |
| DE69616551T2 (de) * | 1995-07-04 | 2002-05-29 | Akzo Nobel N.V., Arnheim/Arnhem | Ringförmige vorrichtung |
| US5972372A (en) * | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
| US6063395A (en) * | 1998-11-12 | 2000-05-16 | Leiras Oy | Drug delivery device especially for the delivery of progestins and estrogens |
| HUP0401438A3 (en) * | 2001-08-31 | 2008-04-28 | Schering Oy | Drug delivery system |
| US7833545B2 (en) * | 2003-04-29 | 2010-11-16 | The General Hospital Corporation | Methods and devices for the sustained release of multiple drugs |
| CA2559224C (en) * | 2004-03-24 | 2011-12-13 | N.V. Organon | Drug delivery system based on polyethylene vinylacetate copolymers |
| EP1853272A1 (en) * | 2005-02-03 | 2007-11-14 | Duramed Pharmaceuticals, Inc. | Compositions of unconjugated estrogens and methods for their use |
-
2007
- 2007-11-22 DK DK07397043.6T patent/DK2062569T3/da active
- 2007-11-22 PL PL07397043T patent/PL2062569T3/pl unknown
- 2007-11-22 EP EP07397043A patent/EP2062569B1/en not_active Not-in-force
- 2007-11-22 AT AT07397043T patent/ATE508734T1/de active
- 2007-11-22 PT PT07397043T patent/PT2062569E/pt unknown
- 2007-11-22 ES ES07397043T patent/ES2365552T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL2062569T3 (pl) | 2011-10-31 |
| EP2062569B1 (en) | 2011-05-11 |
| EP2062569A1 (en) | 2009-05-27 |
| PT2062569E (pt) | 2011-07-25 |
| ES2365552T3 (es) | 2011-10-06 |
| ATE508734T1 (de) | 2011-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201070639A1 (ru) | Вагинальная система доставки | |
| WO2007117465A3 (en) | Indazole compounds | |
| WO2006084164A3 (en) | Gastric retention and controlled release delivery system | |
| AR048185A1 (es) | Sistema de entrega de farmacos constituido por uno o mas compartimentos, que comprende un compuesto progestagenico disuelto en un copolimero de polietileno acetato de vinilo termoplastico | |
| WO2006048747A8 (en) | Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound | |
| WO2006127618A3 (en) | Compressible gum based delivery systems for the release of ingredients | |
| DE602005002745D1 (de) | Medizinische vorrichtungen und verfahren zu ihrer herstellung | |
| WO2008051942A3 (en) | Farnesoid x receptor agonists | |
| WO2007076260A3 (en) | Farnesoid x receptor agonists | |
| WO2007084728A3 (en) | 2-imino-benzimidazoles | |
| EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
| NO20070805L (no) | Medikamentavleveringssystem. | |
| WO2008123582A1 (ja) | テトラヒドロイソキノリン化合物 | |
| AR055755A1 (es) | Derivado de bencimidazol, procesos de obtencion, composiciones farmaceuticas y usos. | |
| DK2062569T3 (da) | Vaginalt afgivelsessystem | |
| BRPI0608287A2 (pt) | agente endoparasiticida | |
| DE602005009812D1 (de) | Abgabesystem für wirkstoff | |
| AR076588A1 (es) | Sistema de liberacion vaginal | |
| CA2526954A1 (en) | Antibiotics containing bone substitute material with sustained active substance release | |
| FR2894143B1 (fr) | Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation. | |
| PT2190431E (pt) | Composições compreendendo um agonista do recetor dos glucocorticoides dissociados para tratamento ou controlo de inflamação do segmento anterior | |
| WO2007028513A3 (de) | Applikationssystem für ein wirkstoffhaltiges pflaster und wirkstoffabgaberegulierungsmittel | |
| WO2008022745A8 (de) | Formulierungen zur kontrollierten freisetzung agrochemischer wirkstoffe | |
| NO20064978L (no) | Farmasoytisk preparat inneholdende drospirenon for paforing pa huden | |
| CL2007002563A1 (es) | Compuestos derivados de fenoxi-fenil-acetamida; proceso de preparacion; composicion farmaceutica; kit farmaceutico; y uso como agente de diagnostico de imagenes. |